Dose Escalation of Carboplatin and Cyclophosphamide Supported by GM-CSF in the Treatment of Patients with Advanced Ovarian Cancer (FIGO III and IV) – a Phase I Study

1999

Summary Background: Up to 75% of ovarian cancers are diagnosed in advanced, incurable stage. Only one fifth of these patients survives 5 years despi

Keywords:

References

Citations